{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:41:29Z","timestamp":1792636889169,"version":"4.5.0"},"reference-count":160,"publisher":"Harborside Press, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.<\/jats:p>","DOI":"10.6004\/jnccn.2026.0027","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:47:56Z","timestamp":1781527676000},"page":"272-277","source":"Crossref","is-referenced-by-count":6,"title":["Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology"],"prefix":"10.6004","volume":"24","author":[{"given":"Susan M.","family":"Swetter","sequence":"first","affiliation":[{"name":"Stanford Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Johnson","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Albertini","sequence":"additional","affiliation":[{"name":"University of Wisconsin Carbone Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Barker","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bateni","sequence":"additional","affiliation":[{"name":"O\u2019Neal Comprehensive Cancer Center at UAB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailender","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bichakjian","sequence":"additional","affiliation":[{"name":"University of Michigan Rogel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Boland","sequence":"additional","affiliation":[{"name":"Mass General Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunandana","family":"Chandra","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chen","sequence":"additional","affiliation":[{"name":"Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Chmielowski","sequence":"additional","affiliation":[{"name":"UCLA Jonsson Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Choi","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"DiMaio","sequence":"additional","affiliation":[{"name":"Fred & Pamela Buffett Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Dronca","sequence":"additional","affiliation":[{"name":"Mayo Clinic Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Fleming","sequence":"additional","affiliation":[{"name":"The University of Tennessee Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Galan","sequence":"additional","affiliation":[{"name":"Yale Cancer Center\/Smilow Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Guild","sequence":"additional","affiliation":[{"name":"AIM at Melanoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Hu-Lieskovan","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute at the University of Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Karakousis","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Kendra","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Kiuru","sequence":"additional","affiliation":[{"name":"UC Davis Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Lange","sequence":"additional","affiliation":[{"name":"Johns Hopkins Kimmel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Lanning","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Logan","sequence":"additional","affiliation":[{"name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Materin","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Nelson","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Olson","sequence":"additional","affiliation":[{"name":"The UChicago Medicine Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Olszanski","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Ott","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Brigham and Women's Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Puzanov","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Rothermel","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April K.","family":"Salama","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Shannon","sequence":"additional","affiliation":[{"name":"UT Southwestern Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[{"name":"UT Southwestern Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Singh","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stacey","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Tsai","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wuthrick","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xing","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McMillian","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Espinosa","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"CA Cancer J Clin","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel RL","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS,  Cancer statistics, 2026. CA Cancer J Clin 2026;76:e70043."},{"key":"B2","series-title":"JAMA Oncol","first-page":"755","article-title":"Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018","volume":"8","author":"Chen ML","year":"2022","unstructured":"Chen ML, de Vere Hunt IJ, John EM,  Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018. JAMA Oncol 2022;8:755\u2013759."},{"key":"B3","series-title":"Cancer","first-page":"386","article-title":"Dysplastic nevi. Markers for increased risk for melanoma","volume":"63","author":"Rigel DS","year":"1989","unstructured":"Rigel DS, Rivers JK, Kopf AW,  Dysplastic nevi. Markers for increased risk for melanoma. Cancer 1989;63:386\u2013389."},{"key":"B4","series-title":"J Am Acad Dermatol","first-page":"847","article-title":"The association of indoor tanning and melanoma in adults: systematic review and meta-analysis","volume":"70","author":"Colantonio S","year":"2014","unstructured":"Colantonio S, Bracken MB, Beecker J. The association of indoor tanning and melanoma in adults: systematic review and meta-analysis. J Am Acad Dermatol 2014;70:847\u2013857.e1\u201318."},{"key":"B5","series-title":"Melanoma Res","first-page":"348","article-title":"Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study","volume":"25","author":"Gordon D","year":"2015","unstructured":"Gordon D, Gillgren P, Eloranta S,  Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study. Melanoma Res 2015;25:348\u2013356."},{"key":"B6","series-title":"Curr Dermatol Rep","first-page":"24","article-title":"Update on the epidemiology of melanoma","volume":"2","author":"Chen ST","year":"2013","unstructured":"Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep 2013;2:24\u201334."},{"key":"B7","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1080","article-title":"Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study","volume":"23","author":"Wu S","year":"2014","unstructured":"Wu S, Han J, Laden F, Qureshi AA. Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomarkers Prev 2014;23:1080\u20131089."},{"key":"B8","series-title":"J Clin Oncol","first-page":"3096","article-title":"Risk factors for melanoma among survivors of non-hodgkin lymphoma","volume":"33","author":"Lam CJ","year":"2015","unstructured":"Lam CJ, Curtis RE, Dores GM,  Risk factors for melanoma among survivors of non-hodgkin lymphoma. J Clin Oncol 2015;33:3096\u20133104."},{"key":"B9","series-title":"Melanoma Res","first-page":"188","article-title":"Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies","volume":"26","author":"Olsen CM","year":"2016","unstructured":"Olsen CM, Lane SW, Green AC. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies. Melanoma Res 2016;26:188\u2013194."},{"key":"B10","series-title":"Pediatr Blood Cancer","first-page":"461","article-title":"Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"60","author":"Pappo AS","year":"2013","unstructured":"Pappo AS, Armstrong GT, Liu W,  Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2013;60:461\u2013466."},{"key":"B11","series-title":"J Invest Dermatol","first-page":"2657","article-title":"Melanoma risk and survival among organ transplant recipients","volume":"135","author":"Robbins HA","year":"2015","unstructured":"Robbins HA, Clarke CA, Arron ST,  Melanoma risk and survival among organ transplant recipients. J Invest Dermatol 2015;135:2657\u20132665."},{"key":"B12","series-title":"JAMA Dermatol","first-page":"177","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland SH","year":"2016","unstructured":"Omland SH, Gniadecki R, H\u00e6dersdal M,  Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol 2016;152:177\u2013183."},{"key":"B13","series-title":"PLoS One","first-page":"e95096","article-title":"Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies","volume":"9","author":"Olsen CM","year":"2014","unstructured":"Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS One 2014;9:e95096."},{"key":"B14","series-title":"Arch Dermatol","first-page":"241","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer KH","year":"1987","unstructured":"Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241\u2013250."},{"key":"B15","series-title":"J Med Genet","first-page":"255","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien V","year":"2013","unstructured":"Bubien V, Bonnet F, Brouste V,  High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 2013;50:255\u2013263."},{"key":"B16","series-title":"Clin Cancer Res","first-page":"400","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan MH","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J,  Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18:400\u2013407."},{"key":"B17","series-title":"Cancer Metastasis Rev","first-page":"77","article-title":"Identification, genetic testing, and management of hereditary melanoma","volume":"36","author":"Leachman SA","year":"2017","unstructured":"Leachman SA, Lucero OM, Sampson JE,  Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 2017;36:77\u201390."},{"key":"B18","series-title":"Eur J Cancer","first-page":"2659","article-title":"Multiple primary (even in situ) melanomas in a patient pose significant risk to family members","volume":"50","author":"Chen T","year":"2014","unstructured":"Chen T, Hemminki K, Kharazmi E,  Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer 2014;50:2659\u20132667."},{"key":"B19","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1557","article-title":"Indoor tanning and risk of melanoma: a case-control study in a highly exposed population","volume":"19","author":"Lazovich D","year":"2010","unstructured":"Lazovich D, Vogel RI, Berwick M,  Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010;19:1557\u20131568."},{"key":"B20","series-title":"Int J Cancer","first-page":"2425","article-title":"Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma","volume":"128","author":"Cust AE","year":"2011","unstructured":"Cust AE, Armstrong BK, Goumas C,  Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011;128:2425\u20132435."},{"key":"B21","series-title":"J Am Acad Dermatol","first-page":"S50","article-title":"Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure","volume":"65","author":"Richards TB","year":"2011","unstructured":"Richards TB, Johnson CJ, Tatalovich Z,  Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure. J Am Acad Dermatol 2011;65:S50\u201357."},{"key":"B22","series-title":"Eur J Cancer","first-page":"3054","article-title":"Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant","volume":"45","author":"Caini S","year":"2009","unstructured":"Caini S, Gandini S, Sera F,  Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009;45:3054\u20133063."},{"key":"B23","series-title":"Eur J Cancer","first-page":"45","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini S","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS,  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45\u201360."},{"key":"B24","series-title":"J Clin Oncol","first-page":"3172","article-title":"Anatomic site, sun exposure, and risk of cutaneous melanoma","volume":"24","author":"Whiteman DC","year":"2006","unstructured":"Whiteman DC, Stickley M, Watt P,  Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006;24:3172\u20133177."},{"key":"B25","series-title":"JAMA Dermatol","first-page":"39","article-title":"Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites","volume":"155","author":"Ghiasvand R","year":"2019","unstructured":"Ghiasvand R, Robsahm TE, Green AC,  Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites. JAMA Dermatol 2019;155:39\u201349."},{"key":"B26","series-title":"Int J Cancer","first-page":"1305","article-title":"Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012","volume":"143","author":"Arnold M","year":"2018","unstructured":"Arnold M, de Vries E, Whiteman DC,  Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer 2018;143:1305\u20131314."},{"key":"B27","series-title":"Clin Epidemiol","first-page":"1389","article-title":"Use of immunomodulating drugs and risk of cutaneous melanoma: a nationwide nested case-control study","volume":"12","author":"Berge LAM","year":"2020","unstructured":"Berge LAM, Andreassen BK, Stenehjem JS,  Use of immunomodulating drugs and risk of cutaneous melanoma: a nationwide nested case-control study. Clin Epidemiol 2020;12:1389\u20131401."},{"key":"B28","series-title":"CA Cancer J Clin","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald JE","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR,  Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:472\u2013492."},{"key":"B29","series-title":"J Clin Oncol","first-page":"2452","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch CM","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ,  Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010;28:2452\u20132459."},{"key":"B30","series-title":"Ann Surg Oncol","first-page":"469","article-title":"Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience","volume":"7","author":"Cascinelli N","year":"2000","unstructured":"Cascinelli N, Belli F, Santinami M,  Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469\u2013474."},{"key":"B31","series-title":"J Clin Oncol","first-page":"3782","article-title":"Prognostic factors in metastatic melanoma: a pooled analysis of eastern cooperative oncology group trials","volume":"18","author":"Manola J","year":"2000","unstructured":"Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of eastern cooperative oncology group trials. J Clin Oncol 2000;18:3782\u20133793."},{"key":"B32","series-title":"J Am Coll Surg","first-page":"193","article-title":"Prognostic factors in 1,521 melanoma patients with distant metastases","volume":"181","author":"Barth A","year":"1995","unstructured":"Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995;181:193\u2013201."},{"key":"B33","series-title":"Semin Surg Oncol","first-page":"400","article-title":"Cutaneous melanoma: prognosis and treatment results worldwide","volume":"8","author":"Balch CM.","year":"1992","unstructured":"Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400\u2013414."},{"key":"B34","series-title":"Cancer","first-page":"1148","article-title":"Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials","volume":"91","author":"Unger JM","year":"2001","unstructured":"Unger JM, Flaherty LE, Liu PY,  Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 2001;91:1148\u20131155."},{"key":"B35","series-title":"Cancers (Basel)","first-page":"1455","article-title":"NCDB analysis of melanoma 2004-2015: epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real-world survival benefit of immunotherapy approval","volume":"13","author":"Singh SRK","year":"2021","unstructured":"Singh SRK, Malapati SJ, Kumar R,  NCDB analysis of melanoma 2004-2015: epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real-world survival benefit of immunotherapy approval. Cancers (Basel) 2021;13:1455."},{"key":"B36","series-title":"Cancer Treat Res","first-page":"107","article-title":"Melanoma: clinical presentations","volume":"167","author":"Kibbi N","year":"2016","unstructured":"Kibbi N, Kluger H, Choi JN. Melanoma: clinical presentations. Cancer Treat Res 2016;167:107\u2013129."},{"key":"B37","series-title":"Int J Clin Exp Pathol","first-page":"739","article-title":"Primary mucosal melanomas: a comprehensive review","volume":"5","author":"Mihajlovic M","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012;5:739\u2013753."},{"key":"B38","series-title":"J Clin Oncol","first-page":"4340","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin JA","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24:4340\u20134346."},{"key":"B39","series-title":"Ophthalmology","first-page":"1180","article-title":"American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman lecture","volume":"122","author":"Shields CL","year":"2015","unstructured":"Shields CL, Kaliki S, Furuta M,  American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman lecture. Ophthalmology 2015;122:1180\u20131186."},{"key":"B40","series-title":"J Am Acad Dermatol","first-page":"366","article-title":"Update on primary mucosal melanoma","volume":"71","author":"Tacastacas JD","year":"2014","unstructured":"Tacastacas JD, Bray J, Cohen YK,  Update on primary mucosal melanoma. J Am Acad Dermatol 2014;71:366\u2013375."},{"key":"B41","series-title":"Oncol Ther","first-page":"87","article-title":"Uveal melanoma: a review of the literature","volume":"6","author":"Singh M","year":"2018","unstructured":"Singh M, Durairaj P, Yeung J. Uveal melanoma: a review of the literature. Oncol Ther 2018;6:87\u2013104."},{"key":"B42","series-title":"Arch Neurol","first-page":"347","article-title":"Increased melanoma risk in Parkinson disease: a prospective clinicopathological study","volume":"67","author":"Bertoni JM","year":"2010","unstructured":"Bertoni JM, Arlette JP, Fernandez HH,  Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol 2010;67:347\u2013352."},{"key":"B43","series-title":"JID Innov","first-page":"100173","article-title":"Clinicopathologic characteristics of melanoma in patients with Parkinson disease","volume":"3","author":"Flynn MS","year":"2023","unstructured":"Flynn MS, Robinson C, Patel S,  Clinicopathologic characteristics of melanoma in patients with Parkinson disease. JID Innov 2023;3:100173."},{"key":"B44","series-title":"JAMA Netw Open","first-page":"e2250613","article-title":"Revision of the melanocytic pathology assessment tool and hierarchy for diagnosis classification schema for melanocytic lesions: a consensus statement","volume":"6","author":"Barnhill RL","year":"2023","unstructured":"Barnhill RL, Elder DE, Piepkorn MW,  Revision of the melanocytic pathology assessment tool and hierarchy for diagnosis classification schema for melanocytic lesions: a consensus statement. JAMA Netw Open 2023;6:e2250613."},{"key":"B45","series-title":"Cancer Prev Res (Phila)","first-page":"233","article-title":"Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma","volume":"3","author":"Olsen CM","year":"2010","unstructured":"Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila) 2010;3:233\u2013245."},{"key":"B46","series-title":"BMJ Open","first-page":"e089558","article-title":"Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study","volume":"14","author":"Wu Z","year":"2024","unstructured":"Wu Z, Nickel B, Boroumand F,  Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study. BMJ Open 2024;14:e089558."},{"key":"B47","series-title":"Clin Dermatol","first-page":"306","article-title":"MPATH-Dx version 2.0 schema for melanocytic lesions: a robust tool for standardized diagnostic reporting","volume":"43","author":"Barnhill RL","year":"2025","unstructured":"Barnhill RL, Piepkorn MW, Duncan LM,  MPATH-Dx version 2.0 schema for melanocytic lesions: a robust tool for standardized diagnostic reporting. Clin Dermatol 2025;43:306\u2013314."},{"key":"B48","series-title":"Nature","first-page":"449","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra D","year":"2012","unstructured":"Mitra D, Luo X, Morgan A,  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background. Nature 2012;491:449\u2013453."},{"key":"B49","series-title":"JAMA","first-page":"3146","article-title":"Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals","volume":"258","author":"Rhodes AR","year":"1987","unstructured":"Rhodes AR, Weinstock MA, Fitzpatrick TB,  Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987;258:3146\u20133154."},{"key":"B50","series-title":"Biochemistry, Melanin","author":"Schlessinger DI","year":"2025","unstructured":"Schlessinger DI, Rahimi N, Schlessinger J. Biochemistry, Melanin. Treasure Island, FL: StatPearls Publishing; 2025."},{"key":"B51","series-title":"Cancer","first-page":"707","article-title":"Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications","volume":"75","author":"Marghoob AA","year":"1995","unstructured":"Marghoob AA, Slade J, Salopek TG,  Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995;75:707\u2013714."},{"key":"B52","series-title":"JAMA","first-page":"910","article-title":"Increased cancer mortality following a history of nonmelanoma skin cancer","volume":"280","author":"Kahn HS","year":"1998","unstructured":"Kahn HS, Tatham LM, Patel AV,  Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998;280:910\u2013912."},{"key":"B53","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1686","article-title":"Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review","volume":"19","author":"Wheless L","year":"2010","unstructured":"Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2010;19:1686\u20131695."},{"key":"B54","series-title":"JAMA","first-page":"1891","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels EA","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF,  Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891\u20131901."},{"key":"B55","series-title":"Am J Transplant","first-page":"993","article-title":"Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma","volume":"24","author":"Zwald FO","year":"2024","unstructured":"Zwald FO, Sargen MR, Austin AA,  Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. Am J Transplant 2024;24:993\u20131002."},{"key":"B56","series-title":"Drugs Context","first-page":"2022","article-title":"Xeroderma pigmentosum: an updated review","volume":"11","author":"Leung AK","year":"2022","unstructured":"Leung AK, Barankin B, Lam JM,  Xeroderma pigmentosum: an updated review. Drugs Context 2022;11:2022."},{"key":"B57","series-title":"J Am Acad Dermatol","first-page":"489","article-title":"Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma","volume":"81","author":"Wei EX","year":"2019","unstructured":"Wei EX, Li X, Nan H. Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. J Am Acad Dermatol 2019;81:489\u2013499."},{"key":"B58","series-title":"Cancer","first-page":"639","article-title":"A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors","volume":"97","author":"Goggins WB","year":"2003","unstructured":"Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003;97:639\u2013643."},{"key":"B59","series-title":"Surgery","first-page":"330","article-title":"Multiple primary melanoma: incidence and risk factors in 283 patients","volume":"113","author":"Slingluff CL","year":"1993","unstructured":"Slingluff CL, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery 1993;113:330\u2013339."},{"key":"B60","series-title":"J Am Acad Dermatol","first-page":"395","article-title":"Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura E","year":"2016","unstructured":"Soura E, Eliades PJ, Shannon K,  Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol 2016;74:395\u2013407;quiz 408\u2013310."},{"key":"B61","series-title":"JAMA Dermatol","first-page":"607","article-title":"Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas","volume":"151","author":"Chen T","year":"2015","unstructured":"Chen T, Fallah M, Forsti A,  Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas. JAMA Dermatol 2015;151:607\u2013615."},{"key":"B62","series-title":"J Am Acad Dermatol","first-page":"265","article-title":"Germline cancer susceptibility in individuals with melanoma","volume":"91","author":"Funchain P","year":"2024","unstructured":"Funchain P, Ni Y, Heald B,  Germline cancer susceptibility in individuals with melanoma. J Am Acad Dermatol 2024;91:265\u2013272."},{"key":"B63","series-title":"J Clin Oncol","first-page":"Abstract 9595","article-title":"Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes","volume":"42","author":"Lochrin SE","year":"2024","unstructured":"Lochrin SE, Kemel Y, Stuart J,  Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes. J Clin Oncol 2024;42(Suppl):Abstract 9595."},{"key":"B64","series-title":"Int J Cancer","first-page":"1385","article-title":"Cutaneous melanomas attributable to ultraviolet radiation exposure by state","volume":"147","author":"Islami F","year":"2020","unstructured":"Islami F, Sauer AG, Miller KD,  Cutaneous melanomas attributable to ultraviolet radiation exposure by state. Int J Cancer 2020;147:1385\u20131390."},{"key":"B65","series-title":"Int J Cancer","first-page":"1116","article-title":"The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review","volume":"120","year":"2007","unstructured":"International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007;120:1116\u20131122."},{"key":"B66","series-title":"Sci Adv","first-page":"eady4878","article-title":"Molecular effects of indoor tanning","volume":"11","author":"Gerami P","year":"2025","unstructured":"Gerami P, Tandukar B, Deivendran D,  Molecular effects of indoor tanning. Sci Adv 2025;11:eady4878."},{"key":"B67","series-title":"Arch Dermatol","first-page":"477","article-title":"Association of UV index, latitude, and melanoma incidence in nonwhite populations\u2013US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001","volume":"141","author":"Eide MJ","year":"2005","unstructured":"Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations\u2013US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005;141:477\u2013481."},{"key":"B68","series-title":"Int J Epidemiol","first-page":"dyaf104","article-title":"Occupation as a firefighter and cancer mortality in a population-based cohort in the United States","volume":"54","author":"Teras LR","year":"2025","unstructured":"Teras LR, Diver WR, Mitchell EL,  Occupation as a firefighter and cancer mortality in a population-based cohort in the United States. Int J Epidemiol 2025;54:dyaf104."},{"key":"B69","series-title":"Front Oncol","first-page":"1130754","article-title":"Cancer risk and mortality among firefighters: a meta-analytic review","volume":"13","author":"Lee DJ","year":"2023","unstructured":"Lee DJ, Ahn S, McClure LA,  Cancer risk and mortality among firefighters: a meta-analytic review. Front Oncol 2023;13:1130754."},{"key":"B70","series-title":"Saf Health Work","first-page":"141","article-title":"Firefighting and cancer: a meta-analysis of cohort studies in the context of cancer hazard identification","volume":"14","author":"DeBono NL","year":"2023","unstructured":"DeBono NL, Daniels RD, Beane Freeman LE,  Firefighting and cancer: a meta-analysis of cohort studies in the context of cancer hazard identification. Saf Health Work 2023;14:141\u2013152."},{"key":"B71","series-title":"Am J Ind Med","first-page":"897","article-title":"Prevalence and predictors of skin cancer screening among a sample of US volunteer firefighters","volume":"66","author":"Shah NN","year":"2023","unstructured":"Shah NN, Steinberg MB, Caban-Martinez AJ,  Prevalence and predictors of skin cancer screening among a sample of US volunteer firefighters. Am J Ind Med 2023;66:897\u2013903."},{"key":"B72","series-title":"Am J Ind Med","first-page":"285","article-title":"Cancer risk among career male and female Florida firefighters: evidence from the Florida Firefighter Cancer Registry (1981\u20132014)","volume":"63","author":"Lee DJ","year":"2020","unstructured":"Lee DJ, Koru-Sengul T, Hernandez MN,  Cancer risk among career male and female Florida firefighters: evidence from the Florida Firefighter Cancer Registry (1981\u20132014). Am J Ind Med 2020;63:285\u2013299."},{"key":"B73","series-title":"Am J Ind Med","first-page":"857","article-title":"Cancer incidence in a cohort of Danish firefighters: an extended long-term follow-up 1968\u20132021","volume":"67","author":"Pedersen JE","year":"2024","unstructured":"Pedersen JE, Petersen KU, Andersen MG,  Cancer incidence in a cohort of Danish firefighters: an extended long-term follow-up 1968\u20132021. Am J Ind Med 2024;67:857\u2013864."},{"key":"B74","series-title":"Mil Med","first-page":"e1883","article-title":"Cancer incidence among patients of the U.S. veterans affairs health care system: 2010 update","volume":"182","author":"Zullig LL","year":"2017","unstructured":"Zullig LL, Sims KJ, McNeil R,  Cancer incidence among patients of the U.S. veterans affairs health care system: 2010 update. Mil Med 2017;182:e1883\u20131891."},{"key":"B75","series-title":"J Am Acad Dermatol","first-page":"72","article-title":"Increased relative proportions of advanced melanoma among veterans: a comparative analysis with the surveillance, epidemiology, and end results registry","volume":"87","author":"Chang MS","year":"2022","unstructured":"Chang MS, La J, Trepanowski N,  Increased relative proportions of advanced melanoma among veterans: a comparative analysis with the surveillance, epidemiology, and end results registry. J Am Acad Dermatol 2022;87:72\u201379."},{"key":"B76","series-title":"J Invest Dermatol","first-page":"2871","article-title":"Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan","volume":"135","author":"Powers JG","year":"2015","unstructured":"Powers JG, Patel NA, Powers EM,  Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan. J Invest Dermatol 2015;135:2871\u20132873."},{"key":"B77","series-title":"JAMA Dermatol","first-page":"1107","article-title":"Skin cancer and other dermatologic conditions among US veterans","volume":"160","author":"Rezaei SJ","year":"2024","unstructured":"Rezaei SJ, Kim J, Onyeka S,  Skin cancer and other dermatologic conditions among US veterans. JAMA Dermatol 2024;160:1107\u20131111."},{"key":"B78","series-title":"J Am Acad Dermatol","first-page":"1185","article-title":"Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel","volume":"78","author":"Riemenschneider K","year":"2018","unstructured":"Riemenschneider K, Liu J, Powers JG. Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. J Am Acad Dermatol 2018;78:1185\u20131192."},{"key":"B79","article-title":"H.R.3967 - 117th Congress (2021\u20132022): Honoring our PACT Act of 2022","unstructured":"Library of Congress. H.R.3967 - 117th Congress (2021\u20132022): Honoring our PACT Act of 2022. Accessed April 1, 2026. Available at: https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/3967"},{"key":"B80","series-title":"JAMA Dermatol","first-page":"279","article-title":"Identification of risk factors for acral melanoma in US veterans","volume":"162","author":"Hwang JC","year":"2026","unstructured":"Hwang JC, Huhmann LB, Cho K,  Identification of risk factors for acral melanoma in US veterans. JAMA Dermatol 2026;162:279\u2013291."},{"key":"B1","series-title":"CA Cancer J Clin","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel RL","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS,  Cancer statistics, 2026. CA Cancer J Clin 2026;76:e70043."},{"key":"B2","series-title":"JAMA Oncol","first-page":"755","article-title":"Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018","volume":"8","author":"Chen ML","year":"2022","unstructured":"Chen ML, de Vere Hunt IJ, John EM,  Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018. JAMA Oncol 2022;8:755\u2013759."},{"key":"B3","series-title":"Cancer","first-page":"386","article-title":"Dysplastic nevi. Markers for increased risk for melanoma","volume":"63","author":"Rigel DS","year":"1989","unstructured":"Rigel DS, Rivers JK, Kopf AW,  Dysplastic nevi. Markers for increased risk for melanoma. Cancer 1989;63:386\u2013389."},{"key":"B4","series-title":"J Am Acad Dermatol","first-page":"847","article-title":"The association of indoor tanning and melanoma in adults: systematic review and meta-analysis","volume":"70","author":"Colantonio S","year":"2014","unstructured":"Colantonio S, Bracken MB, Beecker J. The association of indoor tanning and melanoma in adults: systematic review and meta-analysis. J Am Acad Dermatol 2014;70:847\u2013857.e1\u201318."},{"key":"B5","series-title":"Melanoma Res","first-page":"348","article-title":"Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study","volume":"25","author":"Gordon D","year":"2015","unstructured":"Gordon D, Gillgren P, Eloranta S,  Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study. Melanoma Res 2015;25:348\u2013356."},{"key":"B6","series-title":"Curr Dermatol Rep","first-page":"24","article-title":"Update on the epidemiology of melanoma","volume":"2","author":"Chen ST","year":"2013","unstructured":"Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep 2013;2:24\u201334."},{"key":"B7","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1080","article-title":"Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study","volume":"23","author":"Wu S","year":"2014","unstructured":"Wu S, Han J, Laden F, Qureshi AA. Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomarkers Prev 2014;23:1080\u20131089."},{"key":"B8","series-title":"J Clin Oncol","first-page":"3096","article-title":"Risk factors for melanoma among survivors of non-hodgkin lymphoma","volume":"33","author":"Lam CJ","year":"2015","unstructured":"Lam CJ, Curtis RE, Dores GM,  Risk factors for melanoma among survivors of non-hodgkin lymphoma. J Clin Oncol 2015;33:3096\u20133104."},{"key":"B9","series-title":"Melanoma Res","first-page":"188","article-title":"Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies","volume":"26","author":"Olsen CM","year":"2016","unstructured":"Olsen CM, Lane SW, Green AC. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies. Melanoma Res 2016;26:188\u2013194."},{"key":"B10","series-title":"Pediatr Blood Cancer","first-page":"461","article-title":"Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"60","author":"Pappo AS","year":"2013","unstructured":"Pappo AS, Armstrong GT, Liu W,  Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2013;60:461\u2013466."},{"key":"B11","series-title":"J Invest Dermatol","first-page":"2657","article-title":"Melanoma risk and survival among organ transplant recipients","volume":"135","author":"Robbins HA","year":"2015","unstructured":"Robbins HA, Clarke CA, Arron ST,  Melanoma risk and survival among organ transplant recipients. J Invest Dermatol 2015;135:2657\u20132665."},{"key":"B12","series-title":"JAMA Dermatol","first-page":"177","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland SH","year":"2016","unstructured":"Omland SH, Gniadecki R, H\u00e6dersdal M,  Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol 2016;152:177\u2013183."},{"key":"B13","series-title":"PLoS One","first-page":"e95096","article-title":"Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies","volume":"9","author":"Olsen CM","year":"2014","unstructured":"Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS One 2014;9:e95096."},{"key":"B14","series-title":"Arch Dermatol","first-page":"241","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer KH","year":"1987","unstructured":"Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241\u2013250."},{"key":"B15","series-title":"J Med Genet","first-page":"255","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien V","year":"2013","unstructured":"Bubien V, Bonnet F, Brouste V,  High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 2013;50:255\u2013263."},{"key":"B16","series-title":"Clin Cancer Res","first-page":"400","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan MH","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J,  Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18:400\u2013407."},{"key":"B17","series-title":"Cancer Metastasis Rev","first-page":"77","article-title":"Identification, genetic testing, and management of hereditary melanoma","volume":"36","author":"Leachman SA","year":"2017","unstructured":"Leachman SA, Lucero OM, Sampson JE,  Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 2017;36:77\u201390."},{"key":"B18","series-title":"Eur J Cancer","first-page":"2659","article-title":"Multiple primary (even in situ) melanomas in a patient pose significant risk to family members","volume":"50","author":"Chen T","year":"2014","unstructured":"Chen T, Hemminki K, Kharazmi E,  Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer 2014;50:2659\u20132667."},{"key":"B19","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1557","article-title":"Indoor tanning and risk of melanoma: a case-control study in a highly exposed population","volume":"19","author":"Lazovich D","year":"2010","unstructured":"Lazovich D, Vogel RI, Berwick M,  Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010;19:1557\u20131568."},{"key":"B20","series-title":"Int J Cancer","first-page":"2425","article-title":"Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma","volume":"128","author":"Cust AE","year":"2011","unstructured":"Cust AE, Armstrong BK, Goumas C,  Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011;128:2425\u20132435."},{"key":"B21","series-title":"J Am Acad Dermatol","first-page":"S50","article-title":"Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure","volume":"65","author":"Richards TB","year":"2011","unstructured":"Richards TB, Johnson CJ, Tatalovich Z,  Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure. J Am Acad Dermatol 2011;65:S50\u201357."},{"key":"B22","series-title":"Eur J Cancer","first-page":"3054","article-title":"Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant","volume":"45","author":"Caini S","year":"2009","unstructured":"Caini S, Gandini S, Sera F,  Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009;45:3054\u20133063."},{"key":"B23","series-title":"Eur J Cancer","first-page":"45","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini S","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS,  Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45\u201360."},{"key":"B24","series-title":"J Clin Oncol","first-page":"3172","article-title":"Anatomic site, sun exposure, and risk of cutaneous melanoma","volume":"24","author":"Whiteman DC","year":"2006","unstructured":"Whiteman DC, Stickley M, Watt P,  Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006;24:3172\u20133177."},{"key":"B25","series-title":"JAMA Dermatol","first-page":"39","article-title":"Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites","volume":"155","author":"Ghiasvand R","year":"2019","unstructured":"Ghiasvand R, Robsahm TE, Green AC,  Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites. JAMA Dermatol 2019;155:39\u201349."},{"key":"B26","series-title":"Int J Cancer","first-page":"1305","article-title":"Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012","volume":"143","author":"Arnold M","year":"2018","unstructured":"Arnold M, de Vries E, Whiteman DC,  Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer 2018;143:1305\u20131314."},{"key":"B27","series-title":"Clin Epidemiol","first-page":"1389","article-title":"Use of immunomodulating drugs and risk of cutaneous melanoma: a nationwide nested case-control study","volume":"12","author":"Berge LAM","year":"2020","unstructured":"Berge LAM, Andreassen BK, Stenehjem JS,  Use of immunomodulating drugs and risk of cutaneous melanoma: a nationwide nested case-control study. Clin Epidemiol 2020;12:1389\u20131401."},{"key":"B28","series-title":"CA Cancer J Clin","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald JE","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR,  Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:472\u2013492."},{"key":"B29","series-title":"J Clin Oncol","first-page":"2452","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch CM","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ,  Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010;28:2452\u20132459."},{"key":"B30","series-title":"Ann Surg Oncol","first-page":"469","article-title":"Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience","volume":"7","author":"Cascinelli N","year":"2000","unstructured":"Cascinelli N, Belli F, Santinami M,  Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469\u2013474."},{"key":"B31","series-title":"J Clin Oncol","first-page":"3782","article-title":"Prognostic factors in metastatic melanoma: a pooled analysis of eastern cooperative oncology group trials","volume":"18","author":"Manola J","year":"2000","unstructured":"Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of eastern cooperative oncology group trials. J Clin Oncol 2000;18:3782\u20133793."},{"key":"B32","series-title":"J Am Coll Surg","first-page":"193","article-title":"Prognostic factors in 1,521 melanoma patients with distant metastases","volume":"181","author":"Barth A","year":"1995","unstructured":"Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995;181:193\u2013201."},{"key":"B33","series-title":"Semin Surg Oncol","first-page":"400","article-title":"Cutaneous melanoma: prognosis and treatment results worldwide","volume":"8","author":"Balch CM.","year":"1992","unstructured":"Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400\u2013414."},{"key":"B34","series-title":"Cancer","first-page":"1148","article-title":"Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials","volume":"91","author":"Unger JM","year":"2001","unstructured":"Unger JM, Flaherty LE, Liu PY,  Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 2001;91:1148\u20131155."},{"key":"B35","series-title":"Cancers (Basel)","first-page":"1455","article-title":"NCDB analysis of melanoma 2004-2015: epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real-world survival benefit of immunotherapy approval","volume":"13","author":"Singh SRK","year":"2021","unstructured":"Singh SRK, Malapati SJ, Kumar R,  NCDB analysis of melanoma 2004-2015: epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real-world survival benefit of immunotherapy approval. Cancers (Basel) 2021;13:1455."},{"key":"B36","series-title":"Cancer Treat Res","first-page":"107","article-title":"Melanoma: clinical presentations","volume":"167","author":"Kibbi N","year":"2016","unstructured":"Kibbi N, Kluger H, Choi JN. Melanoma: clinical presentations. Cancer Treat Res 2016;167:107\u2013129."},{"key":"B37","series-title":"Int J Clin Exp Pathol","first-page":"739","article-title":"Primary mucosal melanomas: a comprehensive review","volume":"5","author":"Mihajlovic M","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012;5:739\u2013753."},{"key":"B38","series-title":"J Clin Oncol","first-page":"4340","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin JA","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24:4340\u20134346."},{"key":"B39","series-title":"Ophthalmology","first-page":"1180","article-title":"American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman lecture","volume":"122","author":"Shields CL","year":"2015","unstructured":"Shields CL, Kaliki S, Furuta M,  American joint committee on cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman lecture. Ophthalmology 2015;122:1180\u20131186."},{"key":"B40","series-title":"J Am Acad Dermatol","first-page":"366","article-title":"Update on primary mucosal melanoma","volume":"71","author":"Tacastacas JD","year":"2014","unstructured":"Tacastacas JD, Bray J, Cohen YK,  Update on primary mucosal melanoma. J Am Acad Dermatol 2014;71:366\u2013375."},{"key":"B41","series-title":"Oncol Ther","first-page":"87","article-title":"Uveal melanoma: a review of the literature","volume":"6","author":"Singh M","year":"2018","unstructured":"Singh M, Durairaj P, Yeung J. Uveal melanoma: a review of the literature. Oncol Ther 2018;6:87\u2013104."},{"key":"B42","series-title":"Arch Neurol","first-page":"347","article-title":"Increased melanoma risk in Parkinson disease: a prospective clinicopathological study","volume":"67","author":"Bertoni JM","year":"2010","unstructured":"Bertoni JM, Arlette JP, Fernandez HH,  Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol 2010;67:347\u2013352."},{"key":"B43","series-title":"JID Innov","first-page":"100173","article-title":"Clinicopathologic characteristics of melanoma in patients with Parkinson disease","volume":"3","author":"Flynn MS","year":"2023","unstructured":"Flynn MS, Robinson C, Patel S,  Clinicopathologic characteristics of melanoma in patients with Parkinson disease. JID Innov 2023;3:100173."},{"key":"B44","series-title":"JAMA Netw Open","first-page":"e2250613","article-title":"Revision of the melanocytic pathology assessment tool and hierarchy for diagnosis classification schema for melanocytic lesions: a consensus statement","volume":"6","author":"Barnhill RL","year":"2023","unstructured":"Barnhill RL, Elder DE, Piepkorn MW,  Revision of the melanocytic pathology assessment tool and hierarchy for diagnosis classification schema for melanocytic lesions: a consensus statement. JAMA Netw Open 2023;6:e2250613."},{"key":"B45","series-title":"Cancer Prev Res (Phila)","first-page":"233","article-title":"Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma","volume":"3","author":"Olsen CM","year":"2010","unstructured":"Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila) 2010;3:233\u2013245."},{"key":"B46","series-title":"BMJ Open","first-page":"e089558","article-title":"Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study","volume":"14","author":"Wu Z","year":"2024","unstructured":"Wu Z, Nickel B, Boroumand F,  Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study. BMJ Open 2024;14:e089558."},{"key":"B47","series-title":"Clin Dermatol","first-page":"306","article-title":"MPATH-Dx version 2.0 schema for melanocytic lesions: a robust tool for standardized diagnostic reporting","volume":"43","author":"Barnhill RL","year":"2025","unstructured":"Barnhill RL, Piepkorn MW, Duncan LM,  MPATH-Dx version 2.0 schema for melanocytic lesions: a robust tool for standardized diagnostic reporting. Clin Dermatol 2025;43:306\u2013314."},{"key":"B48","series-title":"Nature","first-page":"449","article-title":"An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background","volume":"491","author":"Mitra D","year":"2012","unstructured":"Mitra D, Luo X, Morgan A,  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background. Nature 2012;491:449\u2013453."},{"key":"B49","series-title":"JAMA","first-page":"3146","article-title":"Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals","volume":"258","author":"Rhodes AR","year":"1987","unstructured":"Rhodes AR, Weinstock MA, Fitzpatrick TB,  Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987;258:3146\u20133154."},{"key":"B50","series-title":"Biochemistry, Melanin","author":"Schlessinger DI","year":"2025","unstructured":"Schlessinger DI, Rahimi N, Schlessinger J. Biochemistry, Melanin. Treasure Island, FL: StatPearls Publishing; 2025."},{"key":"B51","series-title":"Cancer","first-page":"707","article-title":"Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications","volume":"75","author":"Marghoob AA","year":"1995","unstructured":"Marghoob AA, Slade J, Salopek TG,  Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995;75:707\u2013714."},{"key":"B52","series-title":"JAMA","first-page":"910","article-title":"Increased cancer mortality following a history of nonmelanoma skin cancer","volume":"280","author":"Kahn HS","year":"1998","unstructured":"Kahn HS, Tatham LM, Patel AV,  Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998;280:910\u2013912."},{"key":"B53","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1686","article-title":"Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review","volume":"19","author":"Wheless L","year":"2010","unstructured":"Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2010;19:1686\u20131695."},{"key":"B54","series-title":"JAMA","first-page":"1891","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels EA","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF,  Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891\u20131901."},{"key":"B55","series-title":"Am J Transplant","first-page":"993","article-title":"Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma","volume":"24","author":"Zwald FO","year":"2024","unstructured":"Zwald FO, Sargen MR, Austin AA,  Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. Am J Transplant 2024;24:993\u20131002."},{"key":"B56","series-title":"Drugs Context","first-page":"2022","article-title":"Xeroderma pigmentosum: an updated review","volume":"11","author":"Leung AK","year":"2022","unstructured":"Leung AK, Barankin B, Lam JM,  Xeroderma pigmentosum: an updated review. Drugs Context 2022;11:2022."},{"key":"B57","series-title":"J Am Acad Dermatol","first-page":"489","article-title":"Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma","volume":"81","author":"Wei EX","year":"2019","unstructured":"Wei EX, Li X, Nan H. Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. J Am Acad Dermatol 2019;81:489\u2013499."},{"key":"B58","series-title":"Cancer","first-page":"639","article-title":"A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors","volume":"97","author":"Goggins WB","year":"2003","unstructured":"Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003;97:639\u2013643."},{"key":"B59","series-title":"Surgery","first-page":"330","article-title":"Multiple primary melanoma: incidence and risk factors in 283 patients","volume":"113","author":"Slingluff CL","year":"1993","unstructured":"Slingluff CL, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery 1993;113:330\u2013339."},{"key":"B60","series-title":"J Am Acad Dermatol","first-page":"395","article-title":"Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome","volume":"74","author":"Soura E","year":"2016","unstructured":"Soura E, Eliades PJ, Shannon K,  Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol 2016;74:395\u2013407;quiz 408\u2013310."},{"key":"B61","series-title":"JAMA Dermatol","first-page":"607","article-title":"Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas","volume":"151","author":"Chen T","year":"2015","unstructured":"Chen T, Fallah M, Forsti A,  Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas. JAMA Dermatol 2015;151:607\u2013615."},{"key":"B62","series-title":"J Am Acad Dermatol","first-page":"265","article-title":"Germline cancer susceptibility in individuals with melanoma","volume":"91","author":"Funchain P","year":"2024","unstructured":"Funchain P, Ni Y, Heald B,  Germline cancer susceptibility in individuals with melanoma. J Am Acad Dermatol 2024;91:265\u2013272."},{"key":"B63","series-title":"J Clin Oncol","first-page":"Abstract 9595","article-title":"Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes","volume":"42","author":"Lochrin SE","year":"2024","unstructured":"Lochrin SE, Kemel Y, Stuart J,  Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes. J Clin Oncol 2024;42(Suppl):Abstract 9595."},{"key":"B64","series-title":"Int J Cancer","first-page":"1385","article-title":"Cutaneous melanomas attributable to ultraviolet radiation exposure by state","volume":"147","author":"Islami F","year":"2020","unstructured":"Islami F, Sauer AG, Miller KD,  Cutaneous melanomas attributable to ultraviolet radiation exposure by state. Int J Cancer 2020;147:1385\u20131390."},{"key":"B65","series-title":"Int J Cancer","first-page":"1116","article-title":"The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review","volume":"120","year":"2007","unstructured":"International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007;120:1116\u20131122."},{"key":"B66","series-title":"Sci Adv","first-page":"eady4878","article-title":"Molecular effects of indoor tanning","volume":"11","author":"Gerami P","year":"2025","unstructured":"Gerami P, Tandukar B, Deivendran D,  Molecular effects of indoor tanning. Sci Adv 2025;11:eady4878."},{"key":"B67","series-title":"Arch Dermatol","first-page":"477","article-title":"Association of UV index, latitude, and melanoma incidence in nonwhite populations\u2013US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001","volume":"141","author":"Eide MJ","year":"2005","unstructured":"Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations\u2013US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005;141:477\u2013481."},{"key":"B68","series-title":"Int J Epidemiol","first-page":"dyaf104","article-title":"Occupation as a firefighter and cancer mortality in a population-based cohort in the United States","volume":"54","author":"Teras LR","year":"2025","unstructured":"Teras LR, Diver WR, Mitchell EL,  Occupation as a firefighter and cancer mortality in a population-based cohort in the United States. Int J Epidemiol 2025;54:dyaf104."},{"key":"B69","series-title":"Front Oncol","first-page":"1130754","article-title":"Cancer risk and mortality among firefighters: a meta-analytic review","volume":"13","author":"Lee DJ","year":"2023","unstructured":"Lee DJ, Ahn S, McClure LA,  Cancer risk and mortality among firefighters: a meta-analytic review. Front Oncol 2023;13:1130754."},{"key":"B70","series-title":"Saf Health Work","first-page":"141","article-title":"Firefighting and cancer: a meta-analysis of cohort studies in the context of cancer hazard identification","volume":"14","author":"DeBono NL","year":"2023","unstructured":"DeBono NL, Daniels RD, Beane Freeman LE,  Firefighting and cancer: a meta-analysis of cohort studies in the context of cancer hazard identification. Saf Health Work 2023;14:141\u2013152."},{"key":"B71","series-title":"Am J Ind Med","first-page":"897","article-title":"Prevalence and predictors of skin cancer screening among a sample of US volunteer firefighters","volume":"66","author":"Shah NN","year":"2023","unstructured":"Shah NN, Steinberg MB, Caban-Martinez AJ,  Prevalence and predictors of skin cancer screening among a sample of US volunteer firefighters. Am J Ind Med 2023;66:897\u2013903."},{"key":"B72","series-title":"Am J Ind Med","first-page":"285","article-title":"Cancer risk among career male and female Florida firefighters: evidence from the Florida Firefighter Cancer Registry (1981\u20132014)","volume":"63","author":"Lee DJ","year":"2020","unstructured":"Lee DJ, Koru-Sengul T, Hernandez MN,  Cancer risk among career male and female Florida firefighters: evidence from the Florida Firefighter Cancer Registry (1981\u20132014). Am J Ind Med 2020;63:285\u2013299."},{"key":"B73","series-title":"Am J Ind Med","first-page":"857","article-title":"Cancer incidence in a cohort of Danish firefighters: an extended long-term follow-up 1968\u20132021","volume":"67","author":"Pedersen JE","year":"2024","unstructured":"Pedersen JE, Petersen KU, Andersen MG,  Cancer incidence in a cohort of Danish firefighters: an extended long-term follow-up 1968\u20132021. Am J Ind Med 2024;67:857\u2013864."},{"key":"B74","series-title":"Mil Med","first-page":"e1883","article-title":"Cancer incidence among patients of the U.S. veterans affairs health care system: 2010 update","volume":"182","author":"Zullig LL","year":"2017","unstructured":"Zullig LL, Sims KJ, McNeil R,  Cancer incidence among patients of the U.S. veterans affairs health care system: 2010 update. Mil Med 2017;182:e1883\u20131891."},{"key":"B75","series-title":"J Am Acad Dermatol","first-page":"72","article-title":"Increased relative proportions of advanced melanoma among veterans: a comparative analysis with the surveillance, epidemiology, and end results registry","volume":"87","author":"Chang MS","year":"2022","unstructured":"Chang MS, La J, Trepanowski N,  Increased relative proportions of advanced melanoma among veterans: a comparative analysis with the surveillance, epidemiology, and end results registry. J Am Acad Dermatol 2022;87:72\u201379."},{"key":"B76","series-title":"J Invest Dermatol","first-page":"2871","article-title":"Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan","volume":"135","author":"Powers JG","year":"2015","unstructured":"Powers JG, Patel NA, Powers EM,  Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan. J Invest Dermatol 2015;135:2871\u20132873."},{"key":"B77","series-title":"JAMA Dermatol","first-page":"1107","article-title":"Skin cancer and other dermatologic conditions among US veterans","volume":"160","author":"Rezaei SJ","year":"2024","unstructured":"Rezaei SJ, Kim J, Onyeka S,  Skin cancer and other dermatologic conditions among US veterans. JAMA Dermatol 2024;160:1107\u20131111."},{"key":"B78","series-title":"J Am Acad Dermatol","first-page":"1185","article-title":"Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel","volume":"78","author":"Riemenschneider K","year":"2018","unstructured":"Riemenschneider K, Liu J, Powers JG. Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. J Am Acad Dermatol 2018;78:1185\u20131192."},{"key":"B79","article-title":"H.R.3967 - 117th Congress (2021\u20132022): Honoring our PACT Act of 2022","unstructured":"Library of Congress. H.R.3967 - 117th Congress (2021\u20132022): Honoring our PACT Act of 2022. Accessed April 1, 2026. Available at: https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/3967"},{"key":"B80","series-title":"JAMA Dermatol","first-page":"279","article-title":"Identification of risk factors for acral melanoma in US veterans","volume":"162","author":"Hwang JC","year":"2026","unstructured":"Hwang JC, Huhmann LB, Cho K,  Identification of risk factors for acral melanoma in US veterans. JAMA Dermatol 2026;162:279\u2013291."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/6\/article-p272.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/6\/article-p272.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/6\/article-p272.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:47:57Z","timestamp":1781527677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/6\/article-p272.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":160,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2026.0027","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}